LPA and spinal cord injury: More practically, these results raise mechanistic questions about the use of this and related anti-LPA antibodies in basic and clinical research, including pre-clinical studies on spinal cord injury [8] and traumatic brain injury [9, 14] in view of their lack of specificity for LPA, and the possibility that other lipids not assessed in this study could further complicate interpretations.